Dabrafenib Mesylate and Rituximab and hyaluronidase human, recombinant Subcutaneous
Determining the interaction of Dabrafenib Mesylate and Rituximab and hyaluronidase human, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dabrafenib
Brand name: Tafinlar
Synonyms: Dabrafenib
Generic Name: hyaluronidase / rituximab
Brand name: Rituxan Hycela
Synonyms: Hyaluronidase and rituximab, Rituximab and Hyaluronidase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dabrafenib Mesylate-Rituximab Intravenous
- Dabrafenib Mesylate-Riva-Amoxicillin
- Dabrafenib Mesylate-Rivaroxaban
- Dabrafenib Mesylate-Rivastigmine
- Dabrafenib Mesylate-Rivastigmine Capsules
- Dabrafenib Mesylate-Rivastigmine Oral Solution
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Dacarbazine
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Dacarbazine Intravenous, Injection
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Daclatasvir
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Daclatasvir Dihydrochloride
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Daclizumab
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Daclizumab Subcutaneous